| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098565 Polyhydroxyalkanoate synthase and gene encoding the same |
| 07/25/2002 | US20020098561 Polypeptide for use in the treatment of thrombosis and arteriosclerosis |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098551 From a hybrid cell formed from the fusion of two or more cells, each of which cell is engineered to express one component of the multimeric protein, as well as a method for screening for successful fusion of the cells |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
| 07/25/2002 | US20020098527 Gene recombinant antibody and antibody fragment thereof |
| 07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
| 07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
| 07/25/2002 | US20020098277 Proteins are reduced with thiol redox proteins and further reacted with cystamine or oxidized glutathione to prevent reoxidation |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | US20020098189 Have specificity for antigens displayed by microorganisms, especially viruses, as well as antigenic sites present on cancer cells and on various types of toxins, and products of toxins |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2434844A1 Methods and compositions for extracting proteins from cells |
| 07/25/2002 | CA2434364A1 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/25/2002 | CA2433394A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432730A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2429942A1 Hydrolase enzymes and their use in kinetic resolution |
| 07/25/2002 | CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | CA2406342A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/25/2002 | CA2331676A1 Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides |
| 07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224942A1 Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases |
| 07/24/2002 | EP1224470A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 07/24/2002 | EP1224318A2 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 07/24/2002 | EP1224314A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 07/24/2002 | EP1224311A1 Recombinant, replication defective celo virus and celo virus dna |
| 07/24/2002 | EP1224298A1 Fibrinolytically active polypeptide |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
| 07/24/2002 | EP1224222A2 Chemokine receptor |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224219A1 Beta-defensins |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224216A1 Mage-a1 peptides presented by hla class ii molecules |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224208A1 Human inwardly rectifying potassium channel subunit |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP0938679B1 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 07/24/2002 | EP0741144B1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof |
| 07/24/2002 | EP0733643B1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 07/24/2002 | EP0719340B1 Cloned glutamic acid decarboxylase |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360678A Early detection of flaviviruses using NS1 glycoprotein |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360636A Modified human granulocyte-colony stimulating factor and process for producing same |
| 07/24/2002 | CN1360633A Fucosyl transferase gene |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1359693A Process for preparing dried soybean polypeptide powder with hypolipemic action |
| 07/24/2002 | CN1088106C Gene engineering process of preparing spinach chloroplast triose phosphate isomerase |
| 07/23/2002 | US6423836 Production and use of human nm23 protein and antibodies therefor |
| 07/23/2002 | US6423828 Genetically engineered insecticidal endotoxins |
| 07/23/2002 | US6423823 Fungicidal, miticidal, and nematocidal omphalotin derivative |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423511 Humanized antibodies |
| 07/23/2002 | US6423509 Generating transferrin polypeptide; obtain vector containing transferrin polypeptide, transform cell, culture, express vector and recover polypeptide |
| 07/23/2002 | US6423508 Polynucleotide sequences of human EDG-1c |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423506 Immunoglobulin for use in food processing, food treatment and evaluting food safety |
| 07/23/2002 | US6423504 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 07/23/2002 | US6423502 Method for screening candidate pesticides using a receptor that binds Bacillus thuringiensis toxin |
| 07/23/2002 | US6423500 Mammalian receptors for interleukin-10 |
| 07/23/2002 | US6423496 Nucleotide sequences for use in the detection, diagnosis and monitoring of mammary gland tumors |
| 07/23/2002 | US6423318 Hepatitis A virus vaccines |
| 07/23/2002 | US6423312 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 07/23/2002 | CA2368791A1 Medicament for the protection against thrombotic diseases |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2261569C Method for mass production of antimicrobial peptide |
| 07/23/2002 | CA2204911C Glial derived neurotrophic factor as a neuroprotective agent |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2091769C Framework mutated antibodies and their preparation |
| 07/23/2002 | CA2087450C Stable and bioactive modified somatotropins |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2066221C Conjugate vaccine for group b streptococcus |
| 07/23/2002 | CA2065146C Fusion proteins, their preparation and use |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002055716A1 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055704A2 Proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055545A1 Antimicrobial pseudopeptides |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |